Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Abbeville › NPI 1255300414
Hospital

Abbeville General Hospital

Abbeville General Hospital was paid $18.92M by Medicaid between Jan 2018 and Dec 2024, across 171 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.

33Billing provider infoABBEVILLE GENERAL HOSPITAL
ABBEVILLE, LA 70510
33aNPI1255300414assigned 03/17/2006
33bProvider typeRural Acute Care Hospital
28Total paid$18.92M
24GClaims386,546
24DCodes billed171
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Louisiana

Rank by total paid#3 of 8
Median peer was paid$12.38M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201853,466$2.00M
201961,223$1.92M
202040,452$1.47M
202156,333$2.96M
202265,736$3.73M
202364,178$4.22M
2024incomplete45,158$2.62M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 25% 29,622 26,994 $4.79M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 22% 14,332 13,035 $4.18M
99282 Emergency department visit for the evaluation and management, low to moderate severity 7.8% 12,877 11,725 $1.47M
41899 Unlisted procedure, dentoalveolar structures 7.2% 2,237 1,980 $1.36M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.9% 3,446 3,069 $1.12M
62323 2.0% 1,623 1,478 $386K
80050 General health panel 1.7% 8,158 7,381 $328K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.7% 6,019 5,279 $314K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 5,615 4,889 $282K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.4% 6,547 6,057 $270K
95811 1.2% 153 146 $232K
80053 Comprehensive metabolic panel 1.2% 30,110 26,550 $232K
159 more codes
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.1% 173 $217K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 240 $212K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.1% 2,588 $204K
71045 Radiologic examination, chest; single view <1% 2,518 $187K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 30,686 $176K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,873 $174K
71046 Radiologic examination, chest; 2 views <1% 2,598 $167K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 5,410 $163K
70450 Computed tomography, head or brain; without contrast material <1% 411 $161K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 4,716 $151K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 4,689 $150K
80061 Lipid panel <1% 11,932 $139K
36415 Collection of venous blood by venipuncture <1% 56,850 $134K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,135 $101K
96361 Intravenous infusion, hydration; each additional hour <1% 283 $94K
81025 <1% 13,015 $94K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,055 $94K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 6,452 $88K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 396 $88K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,417 $84K
76830 Ultrasound, transvaginal <1% 487 $77K
83036 Hemoglobin; glycosylated (A1C) <1% 8,434 $69K
87400 <1% 4,964 $59K
G0378 Hospital observation service, per hour <1% 567 $55K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,107 $54K
81001 <1% 20,621 $48K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 198 $47K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 587 $45K
95806 <1% 151 $37K
77067 Screening mammography, bilateral, including computer-aided detection <1% 223 $33K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 193 $32K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 26 $30K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,437 $29K
83880 <1% 1,137 $24K
84484 <1% 3,250 $23K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 68 $21K
83970 <1% 765 $21K
0240U <1% 153 $20K
73564 <1% 93 $19K
80081 <1% 242 $15K
86480 <1% 289 $15K
83690 <1% 2,647 $14K
82550 <1% 3,012 $13K
82553 <1% 1,857 $13K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 447 $12K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,630 $11K
74019 <1% 170 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 497 $11K
82150 <1% 2,179 $11K
G0379 Direct admission of patient for hospital observation care <1% 268 $10K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 443 $10K
84439 <1% 1,150 $9K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 685 $9K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 359 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,251 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 91 $8K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 97 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,595 $7K
81002 <1% 2,368 $6K
85610 <1% 2,417 $6K
84443 Thyroid stimulating hormone (TSH) <1% 609 $6K
86850 <1% 1,344 $6K
94664 <1% 352 $5K
81003 <1% 3,737 $5K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 17 $5K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 37 $4K
85730 <1% 1,042 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 50 $4K
83020 <1% 295 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 476 $3K
86803 <1% 314 $3K
87420 <1% 250 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 180 $3K
72100 <1% 38 $3K
99223 Prolong inpt eval add15 m <1% 56 $3K
87340 <1% 311 $2K
82570 <1% 690 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 28 $2K
86038 <1% 243 $2K
86592 <1% 554 $2K
83605 <1% 237 $2K
J2704 Injection, propofol, 10 mg <1% 3,869 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 15 $2K
84156 <1% 696 $2K
87634 <1% 28 $2K
84702 <1% 123 $2K
82728 <1% 146 $1K
85018 <1% 1,027 $1K
73610 <1% 13 $1K
86140 <1% 316 $1K
94760 <1% 425 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 47 $1K
87186 <1% 147 $995.45
87040 <1% 124 $987.39
87077 <1% 147 $981.87
85027 <1% 1,763 $967.10
83550 <1% 147 $958.44
83735 <1% 194 $956.99
86431 <1% 226 $952.56
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 118 $873.02
80048 Basic metabolic panel (calcium, ionized) <1% 139 $870.95
86200 <1% 83 $786.86
83540 <1% 159 $769.10
87081 <1% 108 $649.74
82950 <1% 135 $589.00
86901 <1% 228 $575.03
86900 <1% 229 $572.04
82677 <1% 26 $556.14
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 14 $519.96
J3490 Unclassified drugs <1% 1,015 $486.04
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 74 $477.77
J0571 Buprenorphine, oral, 1 mg <1% 207 $462.77
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 75 $459.84
82105 <1% 26 $385.71
80076 <1% 57 $381.38
J3010 Injection, fentanyl citrate, 0.1 mg <1% 815 $369.22
86336 <1% 26 $358.57
82248 <1% 77 $326.37
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,622 $303.26
J1335 Injection, ertapenem sodium, 500 mg <1% 70 $300.32
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,166 $284.18
J0690 Injection, cefazolin sodium, 500 mg <1% 192 $275.90
86225 <1% 26 $274.80
82607 <1% 26 $269.86
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 13 $260.80
84481 <1% 26 $241.74
84100 <1% 77 $225.35
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 506 $222.81
84153 <1% 12 $220.68
82043 <1% 29 $212.90
83721 <1% 91 $189.47
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 15 $171.17
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 23 $164.22
J2270 Injection, morphine sulfate, up to 10 mg <1% 175 $145.82
S0028 Injection, famotidine, 20 mg <1% 13 $94.78
82962 <1% 26 $82.94
84550 <1% 24 $72.32
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 551 $54.29
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 19 $44.83
A9150 Non-prescription drugs <1% 28 $30.16
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 110 $28.46
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 147 $0.00
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) 0% 268 $0.00
T1015 A visit at a community health center or clinic (one all-in rate) 0% 95 $0.00
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 60 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 13 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 144 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 14 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 147 $0.00
92551 0% 51 $0.00
00000 0% 224 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 978 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 992 $0.00
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes 0% 665 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 134 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 287 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 27 $0.00
99308 Subsequent nursing facility care, per day, straightforward 0% 190 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAIR, KELLY (DIRECTOR OF RURAL HEALTH CLINICS)